Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|February 16, 2005
Uptake, intracellular distribution, and novel binding proteins of immunostimulatory CpG oligodeoxynucleotides in microglial cellsZhiren Zhang, Toni Weinschenk, Hermann J Schluesener
Molecular and Cellular Biochemistry|July 14, 2005
Uptake, cellular distribution and novel cellular binding proteins of immunostimulatory CpG oligodeoxynucleotides in glioblastoma cellsZhiren Zhang, Toni Weinschenk, Hermann J Schluesener
Oncoimmunology|March 14, 2013
Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901Steffen Walter, Toni Weinschenk, Carsten Reinhardt, et al.
Immunological Reviews|November 26, 2002
Towards patient-specific tumor antigen selection for vaccinationHans-Georg Rammensee, Toni Weinschenk, Cécile Gouttefangeas, et al.
Journal of Cellular Biochemistry|November 30, 2005
siRNA binding proteins of microglial cells: PKR is an unanticipated ligandZhiren Zhang, Toni Weinschenk, Ketai Guo, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2003
Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition?Simone Kayser, Iris Watermann, Christine Rentzsch, et al.
Biochemical and Biophysical Research Communications|November 1, 2002
Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cellsMartin H Deininger, Toni Weinschenk, Matthias H Morgalla, et al.
European Journal of Immunology|October 21, 2004
Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometryJörn Dengjel, Patrice Decker, Oliver Schoor, et al.
Biotechniques|December 20, 2003
Moderate degradation does not preclude microarray analysis of small amounts of RNAOliver Schoor, Toni Weinschenk, Jörg Hennenlotter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathwaysSilke Appel, Anette Rupf, Markus M Weck, et al.
Pageof 4